BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 8450035)

  • 1. Inhibition of a Plasmodium vinckei cysteine proteinase cures murine malaria.
    Rosenthal PJ; Lee GK; Smith RE
    J Clin Invest; 1993 Mar; 91(3):1052-6. PubMed ID: 8450035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimalarial effects of peptide inhibitors of a Plasmodium falciparum cysteine proteinase.
    Rosenthal PJ; Wollish WS; Palmer JT; Rasnick D
    J Clin Invest; 1991 Nov; 88(5):1467-72. PubMed ID: 1939639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmodium falciparum: inhibitors of lysosomal cysteine proteinases inhibit a trophozoite proteinase and block parasite development.
    Rosenthal PJ; McKerrow JH; Rasnick D; Leech JH
    Mol Biochem Parasitol; 1989 Jun; 35(2):177-83. PubMed ID: 2671722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmodium falciparum: effects of proteinase inhibitors on globin hydrolysis by cultured malaria parasites.
    Rosenthal PJ
    Exp Parasitol; 1995 Mar; 80(2):272-81. PubMed ID: 7895837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimalarial effects in mice of orally administered peptidyl cysteine protease inhibitors.
    Olson JE; Lee GK; Semenov A; Rosenthal PJ
    Bioorg Med Chem; 1999 Apr; 7(4):633-8. PubMed ID: 10353642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimalarial activities of novel synthetic cysteine protease inhibitors.
    Lee BJ; Singh A; Chiang P; Kemp SJ; Goldman EA; Weinhouse MI; Vlasuk GP; Rosenthal PJ
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3810-4. PubMed ID: 14638488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimalarial effects of vinyl sulfone cysteine proteinase inhibitors.
    Rosenthal PJ; Olson JE; Lee GK; Palmer JT; Klaus JL; Rasnick D
    Antimicrob Agents Chemother; 1996 Jul; 40(7):1600-3. PubMed ID: 8807047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cysteine proteinase inhibitors block early steps in hemoglobin degradation by cultured malaria parasites.
    Gamboa de Domínguez ND; Rosenthal PJ
    Blood; 1996 May; 87(10):4448-54. PubMed ID: 8639807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A malarial cysteine proteinase is necessary for hemoglobin degradation by Plasmodium falciparum.
    Rosenthal PJ; McKerrow JH; Aikawa M; Nagasawa H; Leech JH
    J Clin Invest; 1988 Nov; 82(5):1560-6. PubMed ID: 3053784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Plasmodium falciparum digestive vacuole plasmepsins in the specificity and antimalarial mode of action of cysteine and aspartic protease inhibitors.
    Moura PA; Dame JB; Fidock DA
    Antimicrob Agents Chemother; 2009 Dec; 53(12):4968-78. PubMed ID: 19752273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antimalarial effects of phenothiazine inhibitors of a Plasmodium falciparum cysteine protease.
    Domínguez JN; López S; Charris J; Iarruso L; Lobo G; Semenov A; Olson JE; Rosenthal PJ
    J Med Chem; 1997 Aug; 40(17):2726-32. PubMed ID: 9276017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Plasmodium vinckei cysteine proteinase shares unique features with its Plasmodium falciparum analogue.
    Rosenthal PJ
    Biochim Biophys Acta; 1993 Apr; 1173(1):91-3. PubMed ID: 8485161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cysteine proteases of malaria parasites.
    Rosenthal PJ
    Int J Parasitol; 2004 Dec; 34(13-14):1489-99. PubMed ID: 15582526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Falcipain-2 inhibition by suramin and suramin analogues.
    Marques AF; Esser D; Rosenthal PJ; Kassack MU; Lima LM
    Bioorg Med Chem; 2013 Jul; 21(13):3667-73. PubMed ID: 23680445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of efficacies of cysteine protease inhibitors against five strains of Plasmodium falciparum.
    Singh A; Rosenthal PJ
    Antimicrob Agents Chemother; 2001 Mar; 45(3):949-51. PubMed ID: 11181388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stage-specific antimalarial activity of cysteine protease inhibitors.
    Shenai BR; Semenov AV; Rosenthal PJ
    Biol Chem; 2002 May; 383(5):843-7. PubMed ID: 12108550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimalarial effects of C18 fatty acids on Plasmodium falciparum in culture and on Plasmodium vinckei petteri and Plasmodium yoelii nigeriensis in vivo.
    Krugliak M; Deharo E; Shalmiev G; Sauvain M; Moretti C; Ginsburg H
    Exp Parasitol; 1995 Aug; 81(1):97-105. PubMed ID: 7628573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Falcipain inhibitors as potential therapeutics for resistant strains of malaria: a patent review.
    Mane UR; Gupta RC; Nadkarni SS; Giridhar RR; Naik PP; Yadav MR
    Expert Opin Ther Pat; 2013 Feb; 23(2):165-87. PubMed ID: 23228154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Falcipain inhibition as a promising antimalarial target.
    Marco M; Coterón JM
    Curr Top Med Chem; 2012; 12(5):408-44. PubMed ID: 22242849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Falcipains, Plasmodium falciparum cysteine proteases as key drug targets against malaria.
    Teixeira C; Gomes JR; Gomes P
    Curr Med Chem; 2011; 18(10):1555-72. PubMed ID: 21428877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.